top of page

Mysimba

From £109 (112 tablets)

weight management medication

Description:

Mysimba is indicated, as an adjunct to a reduced-calorie diet and increased physical activity, for the management of weight in adult patients.

About the Service:

Objectives of treatment

This treatment is used to reduce the Body Mass Index (BMI) in obese patients (BMI 30+) or in overweight patients (BMI of 27-30) with one or more weight-related co-morbidities.

Who is this treatment available to?

  • Patients aged between 18 and 65 years.

  • Patients with an initial BMI of 30 or greater.


  • Patients with an initial BMI of 27 or greater in the presence of at least one weight-related comorbidity such a

    • Controlled Hypertension (High blood pressure)

    • Dyslipidaemia (abnormal amount of lipids

    • 'bad' cholesterol in your blood.

    • Obstructive sleep apnoea

    • Type 2 diabetes mellitus

This treatment is only available for ages between 18 and 65 years. Booking an appointment or making an enquiry does not guarantee treatment provision. All services are subject to a clinical consultation and suitability assessment with a qualified healthcare professional. Treatment will only proceed if the patient is deemed medically suitable following this assessment.


During booking, only a £30 deposit is required, which will be deducted from the total cost. The remaining payment will be collected at a later stage.


Any cancellation, rescheduling, or missed appointment within 48 hours of the scheduled time will result in the loss of the £30 deposit. If you wish to reschedule, a new £30 deposit will be required to secure the new appointment.



  • Facebook
  • Twitter
  • LinkedIn

GPhC Registration number: 1038758

©Epicare Health Ltd.

bottom of page